Molecular screening and the clinical impacts of BCR‑ABL KD mutations in patients with imatinib‑resistant chronic myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular screening and the clinical impacts of BCR‑ABL KD mutations in patients with imatinib‑resistant chronic myeloid leukemia

Published:2017-12-13 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Koï¿½kan Betï¿½l¹,Toptaş Tayfur²,Atagï¿½ndï¿½z Işik²,Tuğlular Ayşe²,ï¿½zer Ayşe³,Akkiprik Mustafa³

Affiliation:

1. Department of Medical Services and Techniques, Vocational School, Beykent University, Buyukcekmece, 34550 Istanbul, Turkey

2. Department of Hematology, School of Medicine, Marmara University, Maltepe, 34854 Istanbul, Turkey

3. Department of Medical Biology, School of Medicine, Marmara University, Maltepe, 34854 Istanbul, Turkey

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia;Journal of Mass Spectrometry and Advances in the Clinical Lab;2023-04

2. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA;Scientific Reports;2022-07-29

3. Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy;Medical Oncology;2021-08-28

4. Exosomes from Bone Marrow Microenvironment-Derived Mesenchymal Stem Cells Affect CML Cells Growth and Promote Drug Resistance to Tyrosine Kinase Inhibitors;Stem Cells International;2020-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP